Skip to Content

ValueTheMarkets Podcast 022 – with Kieran Callan, CEO of InnovaDerma (IDP)

Today’s guest on the ValueTheMarkets podcast is Kieran Callan, CEO of InnovaDerma (LSE:IDP). InnovaDerma is a developer of life sciences and personal care products with a number of existing products already available through retail outlets such as Superdrug and Boots. The firm’s existing brands include Skinny Tan, Roots, Prolong and Grow Lase and it is looking to extend its range of products.

InnovaDerma released it’s FY2019 final results on 24th September revealing profits before tax had risen 100pc year-on-year to £1.4m. Kieran discusses the company’s expansion plans, its strong business to customer sales, and why he believes the market is yet to price in InnovaDerma’s future growth.

All opinions expressed are those of ValueTheMarkets and the respective guests unless otherwise stated and should not be construed as investment advice or a recommendation to buy shares in any featured Company. Listeners are advised to do their own extensive research before buying shares which, as with all small-cap exploration stocks, should be viewed as high risk. Investors should also seek the advice of a qualified investment adviser or stockbroker as they deem appropriate.

Valuethemarkets.com and Dynamic Investor Relations Ltd are not responsible for the content or accuracy of this article.  News and research are not recommendations to deal, and investments may fall in value so that you could lose some or all of your investment. Past performance is not an indicator of future performance.

  • Stuart Langelaan does not hold any position in the stock(s) and/or financial instrument(s) mentioned in the piece.
  • Stuart Langelaan has not been paid to produce this piece by the company or companies mentioned above.
  • Dynamic Investor Relations Ltd, the owner of ValueTheMarkets.com, has not been paid for the production of this piece by the company or companies mentioned above.

Related Articles

Headlines

teathers app screenshot

App Empowering Private Investors

Crowd Equity for Placings, IPOs and Live Market Blockbuilds, designed to give provate investors access to placements and Intial Public Offerings (IPOs), predominantly on the London Stock Exchange’s Alternative Investment Market (AIM).